BridgeMD
Effect of Roxadustat on Cardiometabolism
EU CTIS ID: 2023-508183-29-00
What this study is testing
To study the effects of roxadustat on glucose and lipid metabolism and cardiovascular function
- Therapeutic use (Phase IV)
A plain-language read of the study's public EU CTIS listing. The study team confirms the details.
Who can take part
You may be able to join if
- Body mass index over 20 kg/m2 and body weight below 100 kg
- Good general health based upon the results of the medical history, laboratory tests, physical examination, and 12-lead ECG as assessed by the investigator
You likely can't join if
- Regular medication (not including hormonal intrauterine device)
- Fear of pricking and previous difficult blood sampling
- Significant diseases
- Systolic blood pressure over 150 mmHg
- Hemoglobin levels above Finnish reference values
- Pregnancy or breast feeding
See the full eligibility criteria
- Body mass index over 20 kg/m2 and body weight below 100 kg
- Good general health based upon the results of the medical history, laboratory tests, physical examination, and 12-lead ECG as assessed by the investigator
- Regular medication (not including hormonal intrauterine device)
- Fear of pricking and previous difficult blood sampling
- Significant diseases
- Systolic blood pressure over 150 mmHg
- Hemoglobin levels above Finnish reference values
- Pregnancy or breast feeding
- WOCBP not using very potent contraception during study periods and one week after
- Previous venous thrombosis or previous convulsions
- Family history of significant venous thrombosis
- Familial galactose intolerance, total lactase deficiency or absorbtion deficiency of glucose and galactose
- Allergy to peanut or soy
- Unable to speak Finnish
- Significant surgery 6 months before trial
- Participation in another clinical trial one month before beginning of the trial
- Abuse of alcohol or medicines or use of drugs
The study team makes the final eligibility decision.
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18-64 years. The study team makes the final eligibility decision.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from EU CTIS; the study team decides eligibility.